Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.260
-0.070 (-3.00%)
May 15, 2026, 4:00 PM EDT - Market closed
Lipocine Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Lipocine stock have an average target of 6.00, which predicts a 165.49% increase from the current stock price of 2.26.
Price Target: $6.00 (+165.49%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Lipocine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $15 | Strong Buy | Maintains | $7 → $15 | +563.72% | Jan 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +209.73% | Nov 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +253.98% | Aug 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +253.98% | Jun 27, 2025 |
Financial Forecast
Revenue This Year
663.00K
from 1.98M
Decreased by -66.46%
Revenue Next Year
1.11M
from 663.00K
Increased by 67.72%
EPS This Year
-1.97
from -1.77
EPS Next Year
-1.68
from -1.97
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 945,000 | 1.1M | |||
| Avg | 663,000 | 1.1M | |||
| Low | 392,000 | 1.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -52.2% | 72.7% | |||
| Avg | -66.5% | 67.7% | |||
| Low | -80.2% | 61.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.01 | -1.73 | |
| Avg | -1.97 | -1.68 | |
| Low | -1.91 | -1.62 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.